Mylan announces court decision that Biogen’s Tecfidera patent is invalid.
Mylan N.V. announced that the U.S. District Court for the Northern District of West Virginia invalidated Biogen’s Tecfidera patent, U.S. Patent No. 8,399,514, for lack of written description…. read more.